Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 73

1.

Expression of IL-23R and IL-17 and the pathology and prognosis of urinary bladder carcinoma.

Liu J, Wang L, Wang T, Wang J.

Oncol Lett. 2018 Oct;16(4):4325-4330. doi: 10.3892/ol.2018.9145. Epub 2018 Jul 13.

2.

p19-Targeting ILP Protein Blockers of IL-23/Th-17 Pro-Inflammatory Axis Displayed on Engineered Bacteria of Food Origin.

Škrlec K, Zadravec P, Hlavničková M, Kuchař M, Vaňková L, Petroková H, Křížová L, Černý J, Berlec A, Malý P.

Int J Mol Sci. 2018 Jul 1;19(7). pii: E1933. doi: 10.3390/ijms19071933.

3.

Targeting Inflammatory T Helper Cells via Retinoic Acid-Related Orphan Receptor Gamma t Is Ineffective to Prevent Allo-Response-Driven Colitis.

Buchele V, Abendroth B, Büttner-Herold M, Vogler T, Rothamer J, Ghimire S, Ullrich E, Holler E, Neurath MF, Hildner K.

Front Immunol. 2018 May 25;9:1138. doi: 10.3389/fimmu.2018.01138. eCollection 2018.

4.

A safety evaluation of guselkumab for the treatment of psoriasis.

Galluzzo M, D'Adamio S, Campione E, Bianchi L, Talamonti M.

Expert Opin Drug Saf. 2018 Jul;17(7):741-751. doi: 10.1080/14740338.2018.1488963. Epub 2018 Jul 4. Review.

PMID:
29897790
5.

Structural Activation of Pro-inflammatory Human Cytokine IL-23 by Cognate IL-23 Receptor Enables Recruitment of the Shared Receptor IL-12Rβ1.

Bloch Y, Bouchareychas L, Merceron R, Składanowska K, Van den Bossche L, Detry S, Govindarajan S, Elewaut D, Haerynck F, Dullaers M, Adamopoulos IE, Savvides SN.

Immunity. 2018 Jan 16;48(1):45-58.e6. doi: 10.1016/j.immuni.2017.12.008. Epub 2017 Dec 26.

PMID:
29287995
6.

p19-targeted ABD-derived protein variants inhibit IL-23 binding and exert suppressive control over IL-23-stimulated expansion of primary human IL-17+ T-cells.

Křížová L, Kuchař M, Petroková H, Osička R, Hlavničková M, Pelák O, Černý J, Kalina T, Malý P.

Autoimmunity. 2017 Mar;50(2):102-113. doi: 10.1080/08916934.2016.1272598. Epub 2017 Jan 19.

PMID:
28100093
7.

IL-23R mutation is associated with ulcerative colitis: A systemic review and meta-analysis.

Peng LL, Wang Y, Zhu FL, Xu WD, Ji XL, Ni J.

Oncotarget. 2017 Jan 17;8(3):4849-4863. doi: 10.18632/oncotarget.13607. Review.

8.

Analysis of the association of single nucleotide polymorphisms of interleukin-23 receptor (IL-23R) and inflammatory bowel disease in a Chinese Han cohort.

Lu ZK, Chen ZR, Zhu JY, Xu Y, Hua X.

Oncotarget. 2016 Oct 18;7(42):67851-67856. doi: 10.18632/oncotarget.12296.

9.

Immunopathogenesis of IBD: Batf as a Key Driver of Disease Activity.

Hildner K, Punkenburg E, Abendroth B, Neurath MF.

Dig Dis. 2016;34 Suppl 1:40-7. doi: 10.1159/000447281. Epub 2016 Aug 22.

PMID:
27548324
11.

Sodium chloride-enriched Diet Enhanced Inflammatory Cytokine Production and Exacerbated Experimental Colitis in Mice.

Monteleone I, Marafini I, Dinallo V, Di Fusco D, Troncone E, Zorzi F, Laudisi F, Monteleone G.

J Crohns Colitis. 2017 Feb;11(2):237-245. doi: 10.1093/ecco-jcc/jjw139. Epub 2016 Jul 29.

PMID:
27473029
12.

Association between single nucleotide polymorphisms in prospective genes and susceptibility to ankylosing spondylitis and inflammatory bowel disease in a single centre in Turkey.

Küçükşahin O, Ateş A, Türkçapar N, Törüner M, Turgay M, Duman T, Şahin A, Yıldızgören MT, Okoh AK, Külahçıoğlu E, Erten Ş, Kınıklı G, Assadpour S, Düzgün N.

Turk J Gastroenterol. 2016 Jul;27(4):317-24. doi: 10.5152/tjg.2016.15466.

13.

T-bet is a key modulator of IL-23-driven pathogenic CD4(+) T cell responses in the intestine.

Krausgruber T, Schiering C, Adelmann K, Harrison OJ, Chomka A, Pearson C, Ahern PP, Shale M, Oukka M, Powrie F.

Nat Commun. 2016 May 19;7:11627. doi: 10.1038/ncomms11627.

14.

Correlation of Serum Vitamin A Levels with Disease Activity Indices and Colonic IL-23R and FOXP3 mRNA Expression in Ulcerative Colitis Patients.

Verma P, Subodh S, Tiwari V, Rampal R, Tuteja A, Toteja GS, Gupta SD, Ahuja V.

Scand J Immunol. 2016 Aug;84(2):110-7. doi: 10.1111/sji.12450.

15.

Integrative Phosphoproteomics Links IL-23R Signaling with Metabolic Adaptation in Lymphocytes.

Lochmatter C, Fischer R, Charles PD, Yu Z, Powrie F, Kessler BM.

Sci Rep. 2016 Apr 15;6:24491. doi: 10.1038/srep24491.

16.

mTOR Mediates IL-23 Induction of Neutrophil IL-17 and IL-22 Production.

Chen F, Cao A, Yao S, Evans-Marin HL, Liu H, Wu W, Carlsen ED, Dann SM, Soong L, Sun J, Zhao Q, Cong Y.

J Immunol. 2016 May 15;196(10):4390-9. doi: 10.4049/jimmunol.1501541. Epub 2016 Apr 11.

17.

Protective role of R381Q (rs11209026) polymorphism in IL-23R gene in immune-mediated diseases: A comprehensive review.

Abdollahi E, Tavasolian F, Momtazi-Borojeni AA, Samadi M, Rafatpanah H.

J Immunotoxicol. 2016 May;13(3):286-300. doi: 10.3109/1547691X.2015.1115448. Epub 2016 Apr 4. Review.

PMID:
27043356
18.

Association of Interleukin-23 receptor gene polymorphisms with susceptibility to Crohn's disease: A meta-analysis.

Xu WD, Xie QB, Zhao Y, Liu Y.

Sci Rep. 2015 Dec 18;5:18584. doi: 10.1038/srep18584.

19.

IRAK1 Drives Intestinal Inflammation by Promoting the Generation of Effector Th Cells with Optimal Gut-Homing Capacity.

Heiseke AF, Jeuk BH, Markota A, Straub T, Lehr HA, Reindl W, Krug AB.

J Immunol. 2015 Dec 15;195(12):5787-94. doi: 10.4049/jimmunol.1501874. Epub 2015 Nov 11.

20.

Differential Requirements for IL-17A and IL-22 in Cecal versus Colonic Inflammation Induced by Helicobacter hepaticus.

Morrison PJ, Ballantyne SJ, Macdonald SJ, Moore JW, Jenkins D, Wright JF, Fouser LA, Kullberg MC.

Am J Pathol. 2015 Dec;185(12):3290-303. doi: 10.1016/j.ajpath.2015.08.015. Epub 2015 Oct 14.

Supplemental Content

Loading ...
Support Center